Depreciation in USD of INTEGRATED BIOPHARMA INC from Q3 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
INTEGRATED BIOPHARMA INC quarterly/annual Depreciation history and change rate from Q3 2011 to Q3 2025.
  • INTEGRATED BIOPHARMA INC Depreciation for the quarter ending 30 Sep 2025 was $77K, a 9.41% decline year-over-year.
  • INTEGRATED BIOPHARMA INC Depreciation for the twelve months ending 30 Sep 2025 was $310K, a 1.59% decline year-over-year.
  • INTEGRATED BIOPHARMA INC annual Depreciation for 2025 was $318K, a 3.58% increase from 2024.
  • INTEGRATED BIOPHARMA INC annual Depreciation for 2024 was $307K, a 12.5% decline from 2023.
  • INTEGRATED BIOPHARMA INC annual Depreciation for 2023 was $351K, a 4.46% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

INTEGRATED BIOPHARMA INC Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $310K $77K -$8K -9.41% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $318K $74K -$1K -1.33% 01 Apr 2025 30 Jun 2025 10-K 23 Sep 2025
Q1 2025 $319K $76K -$1K -1.3% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $320K $83K +$5K +6.41% 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2025
Q3 2024 $315K $85K +$8K +10.4% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 $307K $75K -$9K -10.7% 01 Apr 2024 30 Jun 2024 10-K 23 Sep 2025
Q1 2024 $316K $77K -$9K -10.5% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $325K $78K -$15K -16.1% 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025
Q3 2023 $340K $77K -$11K -12.5% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $351K $84K -$5K -5.62% 01 Apr 2023 30 Jun 2023 10-K 20 Sep 2024
Q1 2023 $356K $86K +$3K +3.61% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 $353K $93K +$14K +17.7% 01 Oct 2022 31 Dec 2022 10-Q 12 Feb 2024
Q3 2022 $339K $88K +$3K +3.53% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $336K $89K +$5K +5.95% 01 Apr 2022 30 Jun 2022 10-K 15 Sep 2023
Q1 2022 $331K $83K $0 0% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $331K $79K -$8K -9.2% 01 Oct 2021 31 Dec 2021 10-Q 10 Feb 2023
Q3 2021 $339K $85K +$2K +2.41% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $337K $84K +$11K +15.1% 01 Apr 2021 30 Jun 2021 10-K 13 Sep 2022
Q1 2021 $326K $83K +$4K +5.06% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $322K $87K +$18K +26.1% 01 Oct 2020 31 Dec 2020 10-Q 10 Feb 2022
Q3 2020 $304K $83K -$8K -8.79% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $312K $73K -$14K -16.1% 01 Apr 2020 30 Jun 2020 10-K 02 Sep 2021
Q1 2020 $326K $79K +$10K +14.5% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2020
Q4 2019 $316K $69K +$3K +4.55% 01 Oct 2019 31 Dec 2019 10-Q 12 Feb 2020
Q3 2019 $313K $91K +$25K +37.9% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 $288K $87K +$37K +74% 01 Apr 2019 30 Jun 2019 10-K 23 Sep 2020
Q1 2019 $251K $69K +$12K +21.1% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 $239K $66K +$9K +15.8% 01 Oct 2018 31 Dec 2018 10-Q 12 Feb 2020
Q3 2018 $230K $66K -$9K -12% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 $239K $50K -$19K -27.5% 01 Apr 2018 30 Jun 2018 10-K 29 Aug 2019
Q1 2018 $258K $57K -$14K -19.7% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $272K $57K -$23K -28.8% 01 Oct 2017 31 Dec 2017 10-Q 15 May 2019
Q3 2017 $295K $75K +$3K +4.17% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 $292K $69K +$3K +4.55% 01 Apr 2017 30 Jun 2017 10-K 12 Sep 2018
Q1 2017 $289K $71K +$6K +9.23% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 $283K $80K +$24K +42.9% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018
Q3 2016 $259K $72K +$13K +22% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $246K $66K $0 0% 01 Apr 2016 30 Jun 2016 10-K 01 Sep 2017
Q1 2016 $246K $65K -$6K -8.45% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 $252K $56K -$14K -20% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017
Q3 2015 $266K $59K -$2K -3.28% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016
Q2 2015 $268K $66K +$8K +13.8% 01 Apr 2015 30 Jun 2015 10-K 02 Sep 2016
Q1 2015 $260K $71K +$11K +18.3% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 $249K $70K +$4K +6.06% 01 Oct 2014 31 Dec 2014 10-Q 19 Feb 2016
Q3 2014 $245K $61K -$8K -11.6% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 $253K $58K -$16K -21.6% 01 Apr 2014 30 Jun 2014 10-K 04 Sep 2015
Q1 2014 $269K $60K -$11K -15.5% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015
Q4 2013 $280K $66K -$5K -7.04% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015
Q3 2013 $285K $69K -$4K -5.48% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014
Q2 2013 $289K $74K -$40K -35.1% 01 Apr 2013 30 Jun 2013 10-K 08 Sep 2014
Q1 2013 $329K $71K -$15K -17.4% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014
Q4 2012 $344K $71K -$2K -2.74% 01 Oct 2012 31 Dec 2012 10-Q/A 13 Feb 2014
Q3 2012 $346K $73K -$13K -15.1% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 $359K $114K 01 Apr 2012 30 Jun 2012 10-K 30 Sep 2013
Q1 2012 $86K 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 $73K 01 Oct 2011 31 Dec 2011 10-Q 19 Feb 2013
Q3 2011 $86K 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012

INTEGRATED BIOPHARMA INC Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $318K +$11K +3.58% 01 Jul 2024 30 Jun 2025 10-K 23 Sep 2025
2024 $307K -$44K -12.5% 01 Jul 2023 30 Jun 2024 10-K 23 Sep 2025
2023 $351K +$15K +4.46% 01 Jul 2022 30 Jun 2023 10-K 20 Sep 2024
2022 $336K -$1K -0.3% 01 Jul 2021 30 Jun 2022 10-K 15 Sep 2023
2021 $337K +$25K +8.01% 01 Jul 2020 30 Jun 2021 10-K 13 Sep 2022
2020 $312K +$24K +8.33% 01 Jul 2019 30 Jun 2020 10-K 02 Sep 2021
2019 $288K +$49K +20.5% 01 Jul 2018 30 Jun 2019 10-K 23 Sep 2020
2018 $239K -$53K -18.2% 01 Jul 2017 30 Jun 2018 10-K 29 Aug 2019
2017 $292K +$46K +18.7% 01 Jul 2016 30 Jun 2017 10-K 12 Sep 2018
2016 $246K -$22K -8.21% 01 Jul 2015 30 Jun 2016 10-K 01 Sep 2017
2015 $268K +$15K +5.93% 01 Jul 2014 30 Jun 2015 10-K 02 Sep 2016
2014 $253K -$36K -12.5% 01 Jul 2013 30 Jun 2014 10-K 04 Sep 2015
2013 $289K -$70K -19.5% 01 Jul 2012 30 Jun 2013 10-K 08 Sep 2014
2012 $359K 01 Jul 2011 30 Jun 2012 10-K 30 Sep 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.